Skip to main content

4 Result(s)

within Dominique Pessayre Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Current Challenges and Controversies in Drug-Induced Liver Injury

    Current key challenges and controversies encountered in the identification of potentially hepatotoxic drugs and the assessment of drug-induced liver injury (DILI) are covered in this article.

    Alberto Corsini, Patricia Ganey, Cynthia Ju, Neil Kaplowitz… in Drug Safety (2012)

  2. No Access

    Article

    Hepatotoxicity of Antitubercular Treatments

    The standard antitubercular regimen currently includes a combination of 3 antitubercular agents: isoniazid, rifampicin (rifampin) and pyrazinamide. Administration of a fourth agent, ethambutol, is recommended ...

    Dr François Durand, Gilles Jebrak, Dominique Pessayre, Michel Fournier… in Drug Safety (1996)

  3. No Access

    Article

    Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin

    The HMG-CoA reductase inhibitor, lovastatin, is known to induce asymptomatic liver dysfunction in a few patients. We report the case of an adult who suffered from clinical hepatitis three months after the onse...

    Sylvie Grimbert, Dominique Pessayre, Claude Degott… in Digestive Diseases and Sciences (1994)

  4. No Access

    Article

    Pancreatic Cholera (W.D.H.A. syndrome)

    Results of light- and electron-microscopic studies of a primary pancreatic tumor and of metastasis in a new case of Pancreatic Cholera (P.C.) are reported. The primary tumor, but not the metastases, contained unu...

    Jean-Claude Rambaud, Annie Galian, Jacques Scotto, Pierre Hautefeuille… in Virchows Archiv A (1975)